Anzeige
Mehr »
Login
Freitag, 10.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
22:07Studie: Wer das frühstückt, wirkt auf andere besonders attraktiv-
22:06Apple Plans On Revamping Siri During AI Reorganization: What's Going On?-
22:06AngloGold Navigates Production Challenges; Golden Minerals Sells Key Assets; Metallus Launches Share Buyback And More: Friday's Top Mining Stories-
22:06What Analysts Are Saying About Xometry Stock-
22:06Analyst Ratings For Nexstar Media Gr-
22:06Where Rithm Capital Stands With Analysts-
22:06The Analyst Landscape: 12 Takes On US Foods Hldg-
22:06Where EPAM Sys Stands With Analysts-
22:06Expert Ratings For Cleanspark-
22:06What the Options Market Tells Us About Papa John's International-
22:06This Is What Whales Are Betting On Insmed-
22:06Market Whales and Their Recent Bets on CSCO Options-
22:06Morgan Group Holding GAAP EPS of -$0.25, revenue of $0.5M-
22:06Nova Vision Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination to June 10, 2024-
22:06Esperion Therapeutics, Inc.: Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)-
22:06Wayne Savings Bancshares Inc.: Wayne Savings Bancshares, Inc. Announces 2024 Special Meeting Voting Results-
22:06Senvest Capital Inc. Reports Results for the First Quarter Ended March 31, 2024-
22:06The Herzfeld Caribbean Basin Fund, Inc. Pays Quarterly Distribution-
22:06CarGurus, Inc.: CarGurus to Present at the J.P. Morgan 52nd Annual Global Technology, Media and Communications Conference-
22:06Cassava Sciences, Inc.: Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam-
Seite:  Weiter >>